PitchSend

Popular
Blog
Companies
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

DR DME 27 ZETA-1 Phase 2b Clinical Trial (APX3330 in DR) Presented by: David Boyer, MD Retina-Vitreous Associates Medical Group Ocuphire David Boyer, MD Chicago Medical School Board-certified Ophthalmologist specializing in treatment of retinal and vitreous diseases Widely-published author and internationally recognized lecturer on retinal research and innovative approaches Investigator in numerous innovative product retinal trials over the last 35 years
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube